Thanks pinch2020! nice finding.So Novartis got whammy within 2...

  1. 7,843 Posts.
    lightbulb Created with Sketch. 647
    Thanks pinch2020! nice finding.

    So Novartis got whammy within 2 months: The US$2.9b acquired myelofibrosis drug Pelabresib halted in late October due to safety issue, and now the UCB's partnered Parkinson's asset fails phase 2 this week.
    presumably Syntara's 5505 and 4782 are the perfect fits of these 2 holes in Novartis's pipeline. would be great If Gary can use his 8 years experience and connections in Novartis to bridge a deal between the 2 companies.
    Just my speculation...


    Last edited by newB: 17/12/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.3¢
Change
0.003(5.00%)
Mkt cap ! $102.4M
Open High Low Value Volume
6.0¢ 6.4¢ 6.0¢ $110.3K 1.768M

Buyers (Bids)

No. Vol. Price($)
1 136674 6.3¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 215185 2
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.